Although it is the first time to reveal DLX5 hypermethylation in myeloid neoplasms, previous study has also proved the phenomena of DLX5 methylation in breast cancer and neuroblastoma tumors by genome‐wide methylation analysis.16, 17. The gene discussed is DLX5; the disease is breast carcinoma.